Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter Cohort.
Mangialardi V, Macchitella G, Vitobello R, Teofilo A, Cavalli N, Lapucci C, Vercellino M, Idini E, Frau J, Iaffaldano P, et al.
Drugs Real World Outcomes. 2026 May 31. PMID: 42223889.Abstract
